CAPR position history
The shares of Capricor Therapeutics (CAPR) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q4: 2,250,400 shares, $31M, 0.16% of portfolio, New
- 2025 Q1: 2,250,400 shares, $21M, 0.12% of portfolio
- 2025 Q2: 41,000 shares, $407K, <0.01% of portfolio, Reduce −98.2%
- 2025 Q3: 82,000 shares, $591K, <0.01% of portfolio, Add +100.0%
- 2025 Q4: 41,000 shares, $1.2M, <0.01% of portfolio, Reduce −50.0%
- 2026 Q1: 41,000 shares, $1.2M, <0.01% of portfolio
- 2026 Q2: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|